Felicidade Santiago
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Felicidade Santiago has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Katarina Kieselova
Department of Dermatology, Centro Hospitalar de Leiria, Leiria, Portugal
18 shared publications - Américo Figueiredo
Department of Dermatology, Coimbra University Hospital, Coimbra, Portugal
12 shared publications Martinha Henrique
Department of Dermatology Leiria Hospital Center Leiria Portugal
11 shared publications- Ricardo Vieira
Department of Dermatology, Coimbra University Hospital, Coimbra, Portugal
10 shared publications - Margarida Gonçalo
Department of Dermatology University Hospital, Unidade Local de Saude de Coimbra Coimbra Portugal
6 shared publications - Martinha Henrique
Department of Dermatology, Centro Hospitalar de Leiria, Leiria, Portugal
6 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
EASI 100 as a Therapeutic Target in Pediatric Atopic Dermatitis
Dupilumab, a monoclonal antibody targeting interleukin‐4 receptor alpha, has shown both robust efficacy and safety in pediatric atopic dermatitis (AD), but data on complete disease control (Eczema Area and Severity Index [EASI] 100) are scarce. A retrospective analysis of 25 pediatric patients at our institution with a median treatment duration of 20 months revealed a significant improvement in EASI scores, with 44.0% achieving EASI 100 at a median of 52 weeks of treatment. No significant differences were found between the group of patients achieving EASI 100 and those who did not. While this study provides additional insight into the efficacy and safety of dupilumab in pediatric AD, its limited sample size underscores the need for larger scale studies focusing on EASI 100 to better understand the factors influencing complete disease control and to optimize treatment strategies for pediatric patients with AD.
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Open AccessEASI 100 as a Therapeutic Target in Pediatric Atopic Dermatitis
Dupilumab, a monoclonal antibody targeting interleukin‐4 receptor alpha, has shown both robust efficacy and safety in pediatric atopic dermatitis (AD), but data on complete disease control (Eczema Area and Severity Index [EASI] 100) are scarce. A retrospective analysis of 25 pediatric patients at our institution with a median treatment duration of 20 months revealed a significant improvement in EASI scores, with 44.0% achieving EASI 100 at a median of 52 weeks of treatment. No significant differences were found between the group of patients achieving EASI 100 and those who did not. While this study provides additional insight into the efficacy and safety of dupilumab in pediatric AD, its limited sample size underscores the need for larger scale studies focusing on EASI 100 to better understand the factors influencing complete disease control and to optimize treatment strategies for pediatric patients with AD.
- Open Access
- 3 June 2024
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 37 (6) , 475-482
Recomendações para o Diagnóstico e Tratamento da Infeção Não Complicada por Chlamydia trachomatis (Não- Linfogranuloma Venéreo) em Portugal
A infeção por Chlamydia trachomatis é a infeção bacteriana sexualmente transmissível mais frequente a nível global. A sua abordagem diagnóstica é desafiante pela existência de um grande número de portadores assintomáticos, e requer uma disponibilização apropriada de testes laboratoriais à população em risco. Em Portugal, a incidência da infeção tem crescido de forma consistente nos últimos anos, pelo que se impõe a necessidade de cuidados redobrados na identificação de casos, rastreio de contactos sexuais e aplicação de medidas terapêuticas eficazes. As presentes recomendações resultam da adaptação à realidade portuguesa dos consensos internacionais em termos de diagnóstico e terapêutica da infeção por Chlamydia trachomatis, e foram formuladas com o objetivo de uniformizar a gestão clínica e laboratorial dos casos sintomáticos e portadores não sintomáticos da infeção em Portugal à luz dos conhecimentos atuais.
- 3 June 2024
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 37 (6) , 475-482
Open AccessRecomendações para o Diagnóstico e Tratamento da Infeção Não Complicada por Chlamydia trachomatis (Não- Linfogranuloma Venéreo) em Portugal
A infeção por Chlamydia trachomatis é a infeção bacteriana sexualmente transmissível mais frequente a nível global. A sua abordagem diagnóstica é desafiante pela existência de um grande número de portadores assintomáticos, e requer uma disponibilização apropriada de testes laboratoriais à população em risco. Em Portugal, a incidência da infeção tem crescido de forma consistente nos últimos anos, pelo que se impõe a necessidade de cuidados redobrados na identificação de casos, rastreio de contactos sexuais e aplicação de medidas terapêuticas eficazes. As presentes recomendações resultam da adaptação à realidade portuguesa dos consensos internacionais em termos de diagnóstico e terapêutica da infeção por Chlamydia trachomatis, e foram formuladas com o objetivo de uniformizar a gestão clínica e laboratorial dos casos sintomáticos e portadores não sintomáticos da infeção em Portugal à luz dos conhecimentos atuais.
- Open Access
- 1 July 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (4) , 536-539
Nódulo ulcerado congênito: histiocitose de células de Langerhans
- 1 July 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (4) , 536-539
Open AccessNódulo ulcerado congênito: histiocitose de células de Langerhans
- Open Access
- 26 April 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (4) , 536-539
Congenital ulcerated nodule: self-healing Langerhans cell histiocytosis
- 26 April 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (4) , 536-539
Open AccessCongenital ulcerated nodule: self-healing Langerhans cell histiocytosis
- Open Access
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 704-709
Baixo nível de educação em saúde como preditor de corticofobia na dermatite atópica
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 704-709
Open AccessBaixo nível de educação em saúde como preditor de corticofobia na dermatite atópica
- Open Access
- 31 August 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 704-709
A low level of health literacy is a predictor of corticophobia in atopic dermatitis
- 31 August 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 704-709
Open AccessA low level of health literacy is a predictor of corticophobia in atopic dermatitis
- Open Access
- 11 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (5) , 1010
Invasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program
Invasive fungal infections (IFI) have significantly increased over the past years due to advances in medical care for the at-risk immunocompromised population. IFI are often difficult to diagnose and manage, and can be associated with substantial morbidity and mortality. This study aims to contribute to understanding the etiology of invasive and subcutaneous fungal infections, their associated risk factors, and to perceive the outcome of patients who developed invasive disease, raising awareness of these infections at a local level but also in a global context. A laboratory surveillance approach was conducted over a seven-year period and included: (i) cases of invasive and subcutaneous fungal infections caused by filamentous/dimorphic fungi, confirmed by either microscopy or positive culture from sterile samples, (ii) cases diagnosed as probable IFI according to the criteria established by EORTC/MSG when duly substantiated. Fourteen Portuguese laboratories were enrolled. Cases included in this study were classified according to the new consensus definitions of invasive fungal diseases (IFD) published in 2020 as follows: proven IFI (N = 31), subcutaneous fungal infection (N = 23). Those proven deep fungal infections (N = 54) totalized 71.1% of the total cases, whereas 28.9% were classified as probable IFI (N = 22). It was possible to identify the etiological fungal agent in 73 cases (96%). Aspergillus was the most frequent genera detected, but endemic dimorphic fungi represented 14.47% (N = 11) of the total cases. Despite the small number of cases, a high diversity of species were involved in deep fungal infections. This fact has implications for clinical and laboratory diagnosis, and on the therapeutic management of these infections, since different species, even within the same genus, can present diverse patterns of susceptibility to antifungals.
- 11 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (5) , 1010
Open AccessInvasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program
Invasive fungal infections (IFI) have significantly increased over the past years due to advances in medical care for the at-risk immunocompromised population. IFI are often difficult to diagnose and manage, and can be associated with substantial morbidity and mortality. This study aims to contribute to understanding the etiology of invasive and subcutaneous fungal infections, their associated risk factors, and to perceive the outcome of patients who developed invasive disease, raising awareness of these infections at a local level but also in a global context. A laboratory surveillance approach was conducted over a seven-year period and included: (i) cases of invasive and subcutaneous fungal infections caused by filamentous/dimorphic fungi, confirmed by either microscopy or positive culture from sterile samples, (ii) cases diagnosed as probable IFI according to the criteria established by EORTC/MSG when duly substantiated. Fourteen Portuguese laboratories were enrolled. Cases included in this study were classified according to the new consensus definitions of invasive fungal diseases (IFD) published in 2020 as follows: proven IFI (N = 31), subcutaneous fungal infection (N = 23). Those proven deep fungal infections (N = 54) totalized 71.1% of the total cases, whereas 28.9% were classified as probable IFI (N = 22). It was possible to identify the etiological fungal agent in 73 cases (96%). Aspergillus was the most frequent genera detected, but endemic dimorphic fungi represented 14.47% (N = 11) of the total cases. Despite the small number of cases, a high diversity of species were involved in deep fungal infections. This fact has implications for clinical and laboratory diagnosis, and on the therapeutic management of these infections, since different species, even within the same genus, can present diverse patterns of susceptibility to antifungals.
- Open Access
- 2 November 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (11) , 774-778
Emerging Cutaneous Phaeohyphomycosis Caused by Alternaria infectoria
Alternaria species belong to a group of opportunistic fungi that causes skin infection mainly in immunosuppressed patients. The authors describe two clinically distinct cases of cutaneous alternariosis caused by Alternaria infectoria in patients under prolonged corticosteroid treatment. Additionally, a brief review of published cases in portuguese patients is conducted.
- 2 November 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (11) , 774-778
Open AccessEmerging Cutaneous Phaeohyphomycosis Caused by Alternaria infectoria
Alternaria species belong to a group of opportunistic fungi that causes skin infection mainly in immunosuppressed patients. The authors describe two clinically distinct cases of cutaneous alternariosis caused by Alternaria infectoria in patients under prolonged corticosteroid treatment. Additionally, a brief review of published cases in portuguese patients is conducted.
- Open Access
- 1 May 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (1) , 17-24
Insights into CANDLE Syndrome
Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome is a recently described chronic autoinflammatory disease, pathophysiologically related to intracellular proteasome/immunoproteasome dysfunction. This review chronicles the recognition of CANDLE syndrome, the developments in the understanding of the pathomechanism, genetic background, and the emerging therapeutic strategies of this condition.
- 1 May 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (1) , 17-24
Open AccessInsights into CANDLE Syndrome
Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome is a recently described chronic autoinflammatory disease, pathophysiologically related to intracellular proteasome/immunoproteasome dysfunction. This review chronicles the recognition of CANDLE syndrome, the developments in the understanding of the pathomechanism, genetic background, and the emerging therapeutic strategies of this condition.
- Open Access
- 12 July 2019
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 77 (2) , 145-152
Pustular Eruptions in Children as Manifestations of Autoinflammatory Diseases
Nowadays, in clinical practice, when attending a child with a pustular eruption and systemic inflammation, it is mandatory to think of an autoinflammatory disease, once infectious causes have been ruled out. Although rare, autoinflammatory disease must be recognized as early as possible, accurately diagnosed (including gene testing), and treated with targeted therapy if available.
- 12 July 2019
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 77 (2) , 145-152
Open AccessPustular Eruptions in Children as Manifestations of Autoinflammatory Diseases
Nowadays, in clinical practice, when attending a child with a pustular eruption and systemic inflammation, it is mandatory to think of an autoinflammatory disease, once infectious causes have been ruled out. Although rare, autoinflammatory disease must be recognized as early as possible, accurately diagnosed (including gene testing), and treated with targeted therapy if available.